We hypothesized that (i) Non-responders would be more insulin sensitive than Responders at baseline and metabolic factors associated with insulin resistance would be attenuated in Non-responders compared with Responders at baseline, and (ii) weight loss would cause a greater change in multiorgan insulin sensitivity and metabolic factors associated with insulin resistance in Responders than Non-responders. This evidence concerns the gene INS and Insulin resistance.